Qi Li, Higgins Craig E, Higgins Stephen P, Law Brian K, Simone Tessa M, Higgins Paul J
Center for Cell Biology & Cancer Research, Albany Medical College, Albany, New York, 12208.
J Cell Biochem. 2014 Oct;115(10):1840-7. doi: 10.1002/jcb.24861.
Plasminogen activator inhibitor type-1 (PAI-1), a major regulator of the plasmin-dependent pericellular proteolytic cascade, is prominently expressed during the tissue response to injury although the factors that impact PAI-1 induction and their role in the repair process are unclear. Kinetic modeling using established biomarkers of cell cycle transit (c-MYC; cyclin D1; cyclin A) in synchronized human (HaCaT) keratinocytes, and previous cytometric assessments, indicated that PAI-1 transcription occurred early after serum-stimulation of quiescent (G0) cells and prior to G1 entry. It was established previously that differential residence of USF family members (USF1→USF2 switch) at the PE2 region E box (CACGTG) characterized the G0 → G1 transition period and the transcriptional status of the PAI-1 gene. A consensus PE2 E box motif (5'-CACGTG-3') at nucleotides -566 to -561 was required for USF/E box interactions and serum-dependent PAI-1 transcription. Site-directed CG → AT substitution at the two central nucleotides inhibited formation of USF/probe complexes and PAI-1 promoter-driven reporter expression. A dominant-negative USF (A-USF) construct or double-stranded PE2 "decoy" attenuated serum- and TGF-β1-stimulated PAI-1 synthesis. Tet-Off induction of an A-USF insert reduced both PAI-1 and PAI-2 transcripts while increasing the fraction of Ki-67(+) cells. Conversely, overexpression of USF2 or adenoviral-delivery of a PAI-1 vector inhibited HaCaT colony expansion indicating that the USF1 → USF2 transition and subsequent PAI-1 transcription are critical events in the epithelial go-or-grow response. Collectively, these data suggest that USF2, and its target gene PAI-1, regulate serum-stimulated keratinocyte growth, and likely the cadence of cell cycle progression in replicatively competent cells as part of the injury repair program.
纤溶酶原激活物抑制剂-1(PAI-1)是纤溶酶依赖性细胞周围蛋白水解级联反应的主要调节因子,在组织对损伤的反应过程中显著表达,尽管影响PAI-1诱导的因素及其在修复过程中的作用尚不清楚。使用已建立的细胞周期进程生物标志物(c-MYC;细胞周期蛋白D1;细胞周期蛋白A)对同步化的人(HaCaT)角质形成细胞进行动力学建模,以及先前的细胞计数评估表明,PAI-1转录在血清刺激静止(G0)细胞后早期发生,且在进入G1期之前。先前已确定,USF家族成员(USF1→USF2转换)在PE2区域E盒(CACGTG)的差异驻留表征了G0→G1过渡期和PAI-1基因的转录状态。USF/E盒相互作用和血清依赖性PAI-1转录需要位于核苷酸-566至-561处的共有PE2 E盒基序(5'-CACGTG-3')。两个中心核苷酸处的定点CG→AT替换抑制了USF/探针复合物的形成以及PAI-1启动子驱动的报告基因表达。显性负性USF(A-USF)构建体或双链PE2“诱饵”减弱了血清和TGF-β1刺激的PAI-1合成。A-USF插入片段的Tet-Off诱导降低了PAI-1和PAI-2转录本,同时增加了Ki-67(+)细胞的比例。相反,USF2的过表达或PAI-1载体的腺病毒递送抑制了HaCaT集落扩增,表明USF1→USF2转换以及随后的PAI-1转录是上皮细胞生长或静止反应中的关键事件。总体而言,这些数据表明,USF2及其靶基因PAI-1调节血清刺激的角质形成细胞生长,并可能作为损伤修复程序的一部分,调节有复制能力细胞中细胞周期进程的节奏。